NasdaqGS - Nasdaq Real Time Price USD

CareMax, Inc. (CMAX)

Compare
2.2800 +0.2400 (+11.76%)
At close: September 16 at 4:00 PM EDT
Loading Chart for CMAX
DELL
  • Previous Close 2.0400
  • Open 2.0800
  • Bid 2.1600 x 100
  • Ask 2.3400 x 100
  • Day's Range 2.0200 - 2.2896
  • 52 Week Range 1.5500 - 85.2000
  • Volume 122,900
  • Avg. Volume 3,047,412
  • Market Cap (intraday) 8.698M
  • Beta (5Y Monthly) 0.76
  • PE Ratio (TTM) --
  • EPS (TTM) -208.9100
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 32.55

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.

www.caremax.com

1,450

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CMAX

View More

Performance Overview: CMAX

Trailing total returns as of 9/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CMAX
84.74%
S&P 500
18.10%

1-Year Return

CMAX
96.51%
S&P 500
26.58%

3-Year Return

CMAX
99.21%
S&P 500
25.72%

5-Year Return

CMAX
99.23%
S&P 500
71.69%

Compare To: CMAX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CMAX

View More

Valuation Measures

Annual
As of 9/16/2024
  • Market Cap

    8.70M

  • Enterprise Value

    505.48M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.01

  • Price/Book (mrq)

    0.40

  • Enterprise Value/Revenue

    0.64

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -99.78%

  • Return on Assets (ttm)

    -10.59%

  • Return on Equity (ttm)

    -328.42%

  • Revenue (ttm)

    784.55M

  • Net Income Avi to Common (ttm)

    -782.86M

  • Diluted EPS (ttm)

    -208.9100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.43M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2M

Research Analysis: CMAX

View More

Company Insights: CMAX

Research Reports: CMAX

View More

People Also Watch